A detailed history of Antipodes Partners LTD transactions in Alcon Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,076,360 shares of ALC stock, worth $92.7 Million. This represents 3.81% of its overall portfolio holdings.

Number of Shares
1,076,360
Holding current value
$92.7 Million
% of portfolio
3.81%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$88.07 - $100.79 $94.8 Million - $108 Million
1,076,360 New
1,076,360 $108 Million

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $42.2B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.